What is the treatment for atrial tachycardia with second-degree Atrioventricular (AV) block?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Atrial Tachycardia with Second-Degree AV Block

For patients with atrial tachycardia complicated by second-degree AV block, permanent pacemaker implantation is indicated, particularly when the block is infranodal (Mobitz type II), while simultaneously addressing the underlying tachyarrhythmia with appropriate antiarrhythmic therapy. 1

Initial Assessment and Management

Determine the Type and Location of AV Block

  • Mobitz Type I (Wenckebach):

    • Usually occurs at the AV node level
    • Progressive PR prolongation before dropped beat
    • Generally narrow QRS complexes
    • Often benign and may not require permanent pacing
  • Mobitz Type II:

    • Usually infranodal (His-Purkinje system)
    • Constant PR interval before dropped beat
    • Often wide QRS complexes
    • Higher risk of progression to complete heart block
    • Requires permanent pacing even if asymptomatic 1

Acute Management

  1. Hemodynamically unstable patients:

    • Immediate synchronized cardioversion 1
    • Prepare for temporary pacing 2
  2. Hemodynamically stable patients:

    • Atropine 0.5-1 mg IV (maximum 3 mg) for symptomatic bradycardia 2
    • Note: Atropine is often ineffective for infranodal (Mobitz type II) block 2
    • If atropine fails, consider epinephrine (2-10 μg/min) or dopamine (2-10 μg/kg/min) infusion 2
  3. Temporary pacing measures:

    • Transcutaneous pacing for unstable patients not responding to medications 2
    • Transvenous temporary pacing for patients refractory to medical therapy 2

Definitive Management

Permanent Pacemaker Indications

  • Class I indications (strongly recommended):

    • Second-degree AV block with symptomatic bradycardia regardless of type or site of block 1
    • Third-degree and advanced second-degree AV block at any anatomic level associated with bradycardia and symptoms 1
    • Type II second-degree AV block (even if asymptomatic) 1
  • Class IIa indications (reasonable):

    • Asymptomatic persistent third-degree AV block with adequate escape rhythm 1

Management of Atrial Tachycardia

After addressing the AV block with pacing, treat the atrial tachycardia with:

  1. Pharmacological options:

    • Beta-blockers (use with caution if AV block persists) 3
    • Consider catheter ablation for recurrent, symptomatic atrial tachycardia 4
  2. Avoid medications that can worsen AV block:

    • Flecainide (can cause sinus bradycardia, sinus arrest, or worsen AV block) 5
    • Diltiazem and verapamil (can exacerbate AV block) 6
    • Digoxin (can worsen AV block) 1

Special Considerations

Reversible Causes

  • Always evaluate for potentially reversible causes of AV block:
    • Electrolyte abnormalities
    • Medication effects (beta-blockers, calcium channel blockers)
    • Lyme disease
    • Enhanced vagal tone
    • Perioperative hypothermia 1

Caution with Medications

  • Even if pacemaker is implanted, use caution with medications that affect cardiac conduction:
    • Flecainide increases PR, QRS, and QT intervals by approximately 25% 5
    • Diltiazem can cause bradycardia and high-degree AV block 6

Prognosis

  • AV block during tachyarrhythmias is not always benign and may indicate underlying conduction system disease 7
  • Studies show that AV block that occurs during medication use often recurs after drug discontinuation, suggesting underlying conduction disease rather than pure drug effect 8

Follow-up

  • Regular evaluation of pacemaker function
  • Monitoring for progression of conduction disease
  • Adjustment of antiarrhythmic therapy as needed

Pitfalls to Avoid

  • Assuming AV block during tachycardia is always functional and benign 7
  • Delaying pacemaker implantation in patients with Mobitz type II block, even if asymptomatic 1
  • Using medications that can worsen AV block (calcium channel blockers, beta-blockers) without appropriate pacing backup 6
  • Attributing AV block solely to medications when underlying conduction disease may be present 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Bradycardia Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Use of beta-blockers in atrial fibrillation.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.